-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
RVL Pharmaceuticals plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2017 to Q2 2023.
- RVL Pharmaceuticals plc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$23.9M, a 97.3% decline year-over-year.
- RVL Pharmaceuticals plc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$68.3M, a 20.8% decline year-over-year.
- RVL Pharmaceuticals plc annual Net Income (Loss) Attributable to Parent for 2022 was -$51.7M, a 20.4% increase from 2021.
- RVL Pharmaceuticals plc annual Net Income (Loss) Attributable to Parent for 2021 was -$64.9M, a 18.4% increase from 2020.
- RVL Pharmaceuticals plc annual Net Income (Loss) Attributable to Parent for 2020 was -$79.6M, a 70.6% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)